AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

Beverley Shea; Barnaby Reeves; G Wells; Micere Thuku; Candyce Hamel; Julian Moran; David Moher; Peter Tugwell; V Welch; Elizabeth kristjansson; David Henry

doi:10.1136/bmj.j4008

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

Beverley Shea, Barnaby Reeves, G Wells, Micere Thuku, Candyce Hamel, Julian Moran, David Moher, Peter Tugwell, V Welch, Elizabeth kristjansson, David Henry

Research output: Contribution to journal › Article (Academic Journal) › peer-review

5486 Citations (Scopus)

1018 Downloads (Pure)

Abstract

The number of published systematic reviews of studies of healthcare interventions has increased rapidly and these are used extensively for clinical and policy decisions. Systematic reviews are subject to a range of biases and increasingly include non-randomised studies of interventions. It is important that users can distinguish high quality reviews. Many instruments have been designed to evaluate different aspects of reviews, but there are few comprehensive critical appraisal instruments. AMSTAR was developed to evaluate systematic reviews of randomised trials. In this paper, we report on the updating of AMSTAR and its adaptation to enable more detailed assessment of systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. With moves to base more decisions on real world observational evidence we believe that AMSTAR 2 will assist decision makers in the identification of high quality systematic reviews, including those based on non-randomised studies of healthcare interventions.

Original language	English
Journal	BMJ
DOIs	https://doi.org/10.1136/bmj.j4008
Publication status	Published - 21 Sept 2017

Research Groups and Themes

BTC (Bristol Trials Centre)
Centre for Surgical Research

Access to Document

10.1136/bmj.j4008

Full-text PDF (final published version)
This is the final published version of the article (version of record). It first appeared online via BMJ at http://www.bmj.com/content/358/bmj.j4008. Please refer to any applicable terms of use of the publisher.
Final published version, 1.15 MB

Handle.net

Persistent link

Professor Barnaby C Reeves
- Barney.Reevesbristol.acuk
- Bristol Medical School (PHS) - Emeritus Professor
Person: Honorary and Visiting Academic

Cite this

@article{39dcd6e137774acfa90f3df8a4ea8857,

title = "AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both",

abstract = "The number of published systematic reviews of studies of healthcare interventions has increased rapidly and these are used extensively for clinical and policy decisions. Systematic reviews are subject to a range of biases and increasingly include non-randomised studies of interventions. It is important that users can distinguish high quality reviews. Many instruments have been designed to evaluate different aspects of reviews, but there are few comprehensive critical appraisal instruments. AMSTAR was developed to evaluate systematic reviews of randomised trials. In this paper, we report on the updating of AMSTAR and its adaptation to enable more detailed assessment of systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. With moves to base more decisions on real world observational evidence we believe that AMSTAR 2 will assist decision makers in the identification of high quality systematic reviews, including those based on non-randomised studies of healthcare interventions.",

author = "Beverley Shea and Barnaby Reeves and G Wells and Micere Thuku and Candyce Hamel and Julian Moran and David Moher and Peter Tugwell and V Welch and Elizabeth kristjansson and David Henry",

year = "2017",

month = sep,

day = "21",

doi = "10.1136/bmj.j4008",

language = "English",

journal = "BMJ",

issn = "0959-8138",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - AMSTAR 2

T2 - a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

AU - Shea, Beverley

AU - Reeves, Barnaby

AU - Wells, G

AU - Thuku, Micere

AU - Hamel, Candyce

AU - Moran, Julian

AU - Moher, David

AU - Tugwell, Peter

AU - Welch, V

AU - kristjansson, Elizabeth

AU - Henry, David

PY - 2017/9/21

Y1 - 2017/9/21

N2 - The number of published systematic reviews of studies of healthcare interventions has increased rapidly and these are used extensively for clinical and policy decisions. Systematic reviews are subject to a range of biases and increasingly include non-randomised studies of interventions. It is important that users can distinguish high quality reviews. Many instruments have been designed to evaluate different aspects of reviews, but there are few comprehensive critical appraisal instruments. AMSTAR was developed to evaluate systematic reviews of randomised trials. In this paper, we report on the updating of AMSTAR and its adaptation to enable more detailed assessment of systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. With moves to base more decisions on real world observational evidence we believe that AMSTAR 2 will assist decision makers in the identification of high quality systematic reviews, including those based on non-randomised studies of healthcare interventions.

AB - The number of published systematic reviews of studies of healthcare interventions has increased rapidly and these are used extensively for clinical and policy decisions. Systematic reviews are subject to a range of biases and increasingly include non-randomised studies of interventions. It is important that users can distinguish high quality reviews. Many instruments have been designed to evaluate different aspects of reviews, but there are few comprehensive critical appraisal instruments. AMSTAR was developed to evaluate systematic reviews of randomised trials. In this paper, we report on the updating of AMSTAR and its adaptation to enable more detailed assessment of systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. With moves to base more decisions on real world observational evidence we believe that AMSTAR 2 will assist decision makers in the identification of high quality systematic reviews, including those based on non-randomised studies of healthcare interventions.

U2 - 10.1136/bmj.j4008

DO - 10.1136/bmj.j4008

M3 - Article (Academic Journal)

C2 - 28935701

SN - 0959-8138

JO - BMJ

JF - BMJ

ER -

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

Abstract

Research Groups and Themes

Access to Document

Handle.net

Fingerprint

Profiles

Professor Barnaby C Reeves

Cite this